- Home
- PTGX vs LILAK Comparison
PTGX vs LILAK Comparison
Compare PTGX & LILAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | LILAK |
|---|---|---|
| Founded | 2006 | 2017 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Cable & Other Pay Television Services |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 1.7B |
| IPO Year | 2016 | 2017 |
Fundamental Metrics
Financial Performance| Metric | PTGX | LILAK |
|---|---|---|
| Price | $142.39 | $8.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 1 |
| Target Price | ★ $108.23 | $8.20 |
| AVG Volume (30 Days) | 543.5K | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.55 |
| EPS | ★ 2.35 | N/A |
| Revenue | N/A | ★ $4,442,200,000.00 |
| Revenue This Year | $874.25 | $1.37 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $60.58 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $62.24 | $4.75 |
| 52 Week High | $160.81 | $9.13 |
Technical Indicators
Market Signals| Indicator | PTGX | LILAK |
|---|---|---|
| Relative Strength Index (RSI) | 46.64 | 50.09 |
| Support Level | $141.95 | $8.21 |
| Resistance Level | $151.24 | $8.54 |
| Average True Range (ATR) | 5.01 | 0.26 |
| MACD | -0.69 | -0.04 |
| Stochastic Oscillator | 47.93 | 42.34 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
About LILAK Liberty Latin America Ltd. Class C
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.